WS

Wes Sterman

North America, California, United States

Description

Wes Sterman founding investor for Gilead.

Investor Profile

Wes Sterman has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wes Sterman frequently co-invest with?

HOF Capital
North America, New York, United States, New York
Co-Investments: 1
ZhenFund
Asia, Beijing, China, Beijing
Co-Investments: 1
Pebblebed
North America, California, United States, San Francisco
Co-Investments: 1
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 1
Obvious Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Olive Capital
North America, California, United States, San Francisco
Co-Investments: 1
Axial VC
North America, California, United States, San Francisco
Co-Investments: 1
Village Global
North America, California, United States, Covina
Co-Investments: 1

Which angels does Wes Sterman often collaborate with?

MP
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Wes Sterman?

Meliora Therapeutics

San Francisco, California, United States

Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform.

BiotechnologyTherapeutics
SeedSep 29, 2022
Amount Raised: $11,000,000